Organ-on-a-chip technology and microfluidic whole-body models for pharmacokinetic drug toxicity screening
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Microscale cell culture platforms better mimic the in vivo cellular microenvironment than conventional, macroscale systems. Microscale cultures therefore elicit a more authentic response from cultured cells, enabling physiologically realistic in vitro tissue models to be constructed. The fabrication of interconnecting microchambers and microchannels allows drug absorption, distribution, metabolism and elimination to be simulated, and enables precise manipulation of fluid flow to replicate blood circulation. Complex, multi‐organ interactions can be investigated using “organ‐on‐a‐chip” toxicology screens. By reproducing the dynamics of multi‐organ interaction, the dynamics of various diseases and drug activities can be studied in mechanistic detail. In this review, we summarize the current status of technologies related to pharmacokinetic‐based drug toxicity testing, and the use of microtechnology for reproducing the interaction between multiple organs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The origins and the future of microfluidics
Whitesides, G. M. (2006) · Nature · doi:10.1038/nature05058 · Cited by 9,687 · cited 2×
“Microfluidics, which deals with very small quantities of liquids (nanoliters to microliters) using channels with dimensions of micrometers, has been largely applied to chemical synthesis and analytical chemistry [6].”
BackgroundMethodReconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 3×
“One prominent example from the Ingber group [18] describes a lung-on-a-chip platform able to respond to bacterial and inflammatory cytokines introduced into alveolar space and replicate drug-induced pulmonary edema [41].”
BackgroundAbbott, A. (2003) · Nature · doi:10.1038/424870a · Cited by 1,234 · cited 1×
“These interactions often exist in three-dimensional (3D) context [3]; (ii) The cellular microenvironment found in vivo is often heterogeneous.”
BackgroundMicroscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219 · cited 3×
“[35] developed a liver-on-a-chip, in which the microscale architecture of the human liver tissue was reproduced by co-culturing hepatocytes and fibroblasts in precisely defined areas.”
BackgroundPDMS absorption of small molecules and consequences in microfluidic applications
Toepke, M. W., & Beebe, D. J. (2006) · Lab on a Chip · doi:10.1039/b612140c · Cited by 1,190 · cited 5×
“J. 2013, 8 6 © 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Ithis work, liver slices were sandwiched between PDMS layers and perfused with media.”
BackgroundInfluentialA Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice
Huh, D., Leslie, D. C., Matthews, B. D., Fraser, J. P., Jurek, S., Hamilton, G. A., Thorneloe, K. S., McAlexander, M. A., & Ingber, D. E. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004249 · Cited by 993 · cited 2×
“One prominent example from the Ingber group [18] describes a lung-on-a-chip platform able to respond to bacterial and inflammatory cytokines introduced into alveolar space and replicate drug-induced pulmonary edema [41].”
BackgroundEngineering of functional, perfusable 3D microvascular networks on a chip
Kim, S., Lee, H., Chung, M., & Jeon, N. L. (2013) · Lab on a Chip · doi:10.1039/c3lc41320a · Cited by 872 · cited 1×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundHuman kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
Jang, K.-J., Mehr, A. P., Hamilton, G. A., McPartlin, L. A., Chung, S., Suh, K.-Y., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40049b · Cited by 849 · cited 1×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundMicroengineered hydrogels for tissue engineering
Khademhosseini, A., & Langer, R. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.07.021 · Cited by 830 · cited 1×
“Therefore, recent research efforts have been directed towards fabricating hydrogels into 3D shapes mimicking the geometry of the target organs [25].”
BackgroundDesign of pressure-driven microfluidic networks using electric circuit analogy
Oh, K. W., Lee, K., Ahn, B., & Furlani, E. P. (2012) · Lab Chip · doi:10.1039/c2lc20799k · Cited by 685 · cited 1×
“The analogy between electrical circuits and microfluidic devices not only applies to a single channel, but it can also be extended to a more complex network of microchannels [30].”
Background
Cited by
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Three-Dimensional Cell Cultures in Drug Discovery and Development
Fang, Y., & Eglen, R. M. (2017) · SLAS Discovery · doi:10.1177/1087057117696795 · Cited by 849
“Integrating multiple organ types into one chip, termed as body-on-a-chip, can be powerful for comprehending the pharmacokinetics and pharmacodynamics of drug molecules.(119,120) However, developing screeningcompatible body-on-a-chip remains a challenging task, in particular when one considers the known allometric scal…”
BackgroundA liver-on-a-chip platform with bioprinted hepatic spheroids
Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615
Lee, H., & Cho, D.-W. (2016) · Lab on a Chip · doi:10.1039/c6lc00450d · Cited by 363
Organ-on-a chip systems: microengineering to biomimic living systems
Zheng, F., Fu, F., Cheng, Y., Wang, C., Zhao, Y., & Gu, Z. (2016) · Small · doi:10.1002/smll.201503208 · Cited by 338
Metadata
- Authors
- Lee, J. B., & Sung, J. H.
- Affiliations
- University of Seoul (KR)
- Hongik University (KR)
- Venue
- Biotechnology Journal
- Publisher
- Wiley
- Published
- 2013-08-23
- Volume
- 8
- Issue
- 11
- Pages
- 1258-1266
- ISSN
- 1860-6768 (ISSN-L)
- 1860-7314
- OpenAlex
- W2015699419
- Cited by
- 92
- References
- 68
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 4 · 2019: 9 · 2018: 11 · 2017: 16 · 2016: 6 · 2015: 7 · 2014: 4 · 2013: 2
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biotechnology Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- organ-on-a-chip, in vitro toxicology
- MeSH terms
- Cells, Cultured, Drug Evaluation, Preclinical, Humans, Models, Biological, Pharmacokinetics, Microfluidics, Cellular Microenvironment, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.